We are live on ! Find out more
GC

GMT Capital Portfolio holdings

AUM $2.19B
1-Year Est. Return 72.3%
This Fund
S&P 500
This Quarter Est. Return
+14.23%
1 Year Est. Return
+72.3%
3 Year Est. Return
+172.46%
5 Year Est. Return
+183.05%
10 Year Est. Return
+942.8%
AUM
$2.66B
AUM Growth
-$2.17M
Cap. Flow
-$289M
Cap. Flow %
-10.89%
Top 10 Hldgs %
62.67%
Holding
110
New
2
Increased
16
Reduced
20
Closed
59

Top Buys

Rank Stock Value
1
ITUB icon
Itaú Unibanco
ITUB
+$24.6M
2
WCC
WESCO International
WCC
+$19.8M
3
KD icon
Kyndryl
KD
+$19.5M
4
RPRX icon
Royalty Pharma
RPRX
+$17.3M
5
HBM icon
Hudbay
HBM
+$16.8M

Top Sells

Rank Stock Value
1
TPR icon
Tapestry
TPR
+$62.7M
2
SOXX icon
iShares Semiconductor ETF
SOXX
+$37.1M
3
SIG icon
Signet Jewelers
SIG
+$36.6M
4
FXI icon
iShares China Large-Cap ETF
FXI
+$26.5M
5
FRPT icon
Freshpet
FRPT
+$18.7M

Sector Composition

Rank Sector Weight
1 Materials 25.39%
2 Consumer Discretionary 23.1%
3 Industrials 20.53%
4 Technology 10.85%
5 Communication Services 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYF icon
26
Synchrony
SYF
$24.7B
$28.6M 1.08%
749,500
-244,500
-25% -$7.74M
TSM icon
27
TSMC
TSM
$2.09T
$27.9M 1.05%
267,900
-53,500
-17% -$5.1M
MRNS
28
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$18.7M 0.71%
1,722,695
– –
NAMS icon
29
NewAmsterdam Pharma
NAMS
$3.47B
$15.5M 0.58%
1,383,800
– –
WBD icon
30
Warner Bros
WBD
$64.8B
$14.8M 0.56%
1,299,900
-298,800
-19% -$3.23M
ANNX icon
31
Annexon
ANNX
$913M
$13.7M 0.52%
3,020,474
+210,003
+7% +$520K
GTE icon
32
Gran Tierra Energy
GTE
$235M
$12.8M 0.48%
2,269,600
-219,231
-9% -$1.36M
AMLX icon
33
Amylyx Pharmaceuticals
AMLX
$1.94B
$11.6M 0.44%
786,000
+209,700
+36% +$3.21M
META icon
34
Meta Platforms (Facebook)
META
$1.64T
$10.5M 0.39%
29,600
-9,400
-24% -$3.06M
RCKT icon
35
Rocket Pharmaceuticals
RCKT
$375M
$9.19M 0.35%
306,500
-104,700
-25% -$2.31M
KNSA icon
36
Kiniksa Pharmaceuticals
KNSA
$4.81B
$5.99M 0.23%
341,553
-136,300
-29% -$2.24M
IRWD icon
37
Ironwood Pharmaceuticals
IRWD
$634M
$4.08M 0.15%
356,400
-104,800
-23% -$1.04M
GPCR icon
38
Structure Therapeutics
GPCR
$3.34B
$3.33M 0.13%
81,700
-31,500
-28% -$1.81M
EA icon
39
Electronic Arts
EA
$52.5B
$3.19M 0.12%
23,320
– –
NMRA icon
40
Neumora Therapeutics
NMRA
$302M
$2.4M 0.09%
+140,666
New +$1.73M
LBRT icon
41
Liberty Energy
LBRT
$3.93B
$2.01M 0.08%
110,974
-40,000
-26% -$760K
SKE
42
Skeena Resources
SKE
$3.11B
$1.91M 0.07%
389,600
– –
HIG icon
43
Hartford Financial Services
HIG
$38.5B
$1.26M 0.05%
+15,700
New +$1.18M
OBE
44
Obsidian Energy
OBE
$628M
$1.22M 0.05%
180,008
– –
BNGO icon
45
Bionano Genomics
BNGO
$13M
$1M 0.04%
8,838
– –
CIEN icon
46
Ciena
CIEN
$53.6B
$424K 0.02%
9,410
– –
MRVL icon
47
Marvell Technology
MRVL
$175B
$338K 0.01%
5,600
– –
OPTN
48
DELISTED
OptiNose
OPTN
$311K 0.01%
16,061
-57,986
-78% -$1.06M
TDW icon
49
Tidewater
TDW
$3.75B
$226K 0.01%
3,140
– –
OCGN icon
50
Ocugen
OCGN
$450M
$177K 0.01%
307,786
-3,614,412
-92% -$1.45M
1
2
3 4 5

Similar funds

CFM
Coronation Fund Managers Cape Town, South Africa $2.19B AUM 3.99% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.19B AUM 20.87% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
SQA
Simon Quick Advisors Morristown, New Jersey $2.19B AUM 17.29% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
ALMGDA
AG2R La Mondiale Gestion d'Actifs Paris, France $2.2B AUM 26.68% 1-Year Est. Return
PVI
Pine Valley Investments Marlton, New Jersey $2.18B AUM 26.57% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

GMT Capital's Q4 2023 Portfolio in Review

As of Q4 2023, GMT Capital held 110 positions worth $2.66B, down 0.08% from $2.66B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

GMT Capital withdrew a net $289M in Q4 2023, closing 59 positions and reducing 20 holdings. Its most notable exit was Tapestry, an estimated $62.7M position sold in full.

By sector, the portfolio is most concentrated in Materials at 25% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, GMT Capital opened a new position in Neumora Therapeutics worth $2.4M.

  • GMT Capital's largest Q4 2023 buy was Neumora Therapeutics: 140,666 shares worth $2.4M.
  • GMT Capital added most to Itaú Unibanco in Q4 2023, an estimated $24.6M increase.
  • GMT Capital's biggest Q4 2023 reduction was Signet Jewelers, cutting an estimated $36.6M.
  • GMT Capital fully exited Tapestry in Q4 2023, selling an estimated $62.7M.
  • GMT Capital's ten largest holdings make up 63% of its $2.66B portfolio in Q4 2023.
  • GMT Capital opened 2 new positions and closed 59 in Q4 2023.
  • GMT Capital's portfolio value fell 0.08% quarter-over-quarter to $2.66B.

Based on GMT Capital's 13F filing for Q4 2023, filed 12 Feb 2024.